These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 16552410

  • 1. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
    Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.
    Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
    [Abstract] [Full Text] [Related]

  • 2. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.
    Int J Obes Relat Metab Disord; 2002 May; 26(5):593-604. PubMed ID: 12032741
    [Abstract] [Full Text] [Related]

  • 3. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
    McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM.
    JAMA; 2004 Jan 14; 291(2):216-21. PubMed ID: 14722148
    [Abstract] [Full Text] [Related]

  • 4. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.
    Greenway FL, De Jonge L, Blanchard D, Frisard M, Smith SR.
    Obes Res; 2004 Jul 14; 12(7):1152-7. PubMed ID: 15292480
    [Abstract] [Full Text] [Related]

  • 5. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
    Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D.
    Int J Obes Relat Metab Disord; 2002 Oct 14; 26(10):1363-6. PubMed ID: 12355332
    [Abstract] [Full Text] [Related]

  • 6. Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.
    Kwak JH, Ahn CW, Park SH, Jung SU, Min BJ, Kim OY, Lee JH.
    Food Funct; 2012 Oct 14; 3(10):1019-24. PubMed ID: 22739624
    [Abstract] [Full Text] [Related]

  • 7. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
    Vukovich MD, Schoorman R, Heilman C, Jacob P, Benowitz NL.
    Clin Exp Pharmacol Physiol; 2005 Oct 14; 32(1-2):47-53. PubMed ID: 15730434
    [Abstract] [Full Text] [Related]

  • 8. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M, Keshavarz SA, Mansouri S, Qorbani M, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G.
    Trials; 2017 Jun 07; 18(1):260. PubMed ID: 28592311
    [Abstract] [Full Text] [Related]

  • 9. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
    Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL.
    Int J Obes Relat Metab Disord; 2001 Mar 07; 25(3):316-24. PubMed ID: 11319627
    [Abstract] [Full Text] [Related]

  • 10. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
    Preuss HG, DiFerdinando D, Bagchi M, Bagchi D.
    J Med; 2002 Mar 07; 33(1-4):247-64. PubMed ID: 12939122
    [Abstract] [Full Text] [Related]

  • 11. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
    Coffey CS, Steiner D, Baker BA, Allison DB.
    Int J Obes Relat Metab Disord; 2004 Nov 07; 28(11):1411-9. PubMed ID: 15356670
    [Abstract] [Full Text] [Related]

  • 12. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals.
    Pal S, Khossousi A, Binns C, Dhaliwal S, Ellis V.
    Br J Nutr; 2011 Jan 07; 105(1):90-100. PubMed ID: 20727237
    [Abstract] [Full Text] [Related]

  • 13. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects.
    Belza A, Frandsen E, Kondrup J.
    Int J Obes (Lond); 2007 Jan 07; 31(1):121-30. PubMed ID: 16652130
    [Abstract] [Full Text] [Related]

  • 14. Green Tea Extract and Catechol-O-Methyltransferase Genotype Modify Fasting Serum Insulin and Plasma Adiponectin Concentrations in a Randomized Controlled Trial of Overweight and Obese Postmenopausal Women.
    Dostal AM, Samavat H, Espejo L, Arikawa AY, Stendell-Hollis NR, Kurzer MS.
    J Nutr; 2016 Jan 07; 146(1):38-45. PubMed ID: 26581683
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J.
    JAMA; 2003 Mar 26; 289(12):1537-45. PubMed ID: 12672771
    [Abstract] [Full Text] [Related]

  • 16. Short-term and long-term in vivo exposure to an ephedra- and caffeine-containing metabolic nutrition system does not induce cardiotoxicity in B6C3F1 mice.
    Ray S, Phadke S, Patel C, Hackman RM, Stohs S.
    Arch Toxicol; 2005 Jun 26; 79(6):330-40. PubMed ID: 15895207
    [Abstract] [Full Text] [Related]

  • 17. Dietary supplementation with bean extract improves lipid profile in overweight and obese subjects.
    Birketvedt GS, Travis A, Langbakk B, Florholmen JR.
    Nutrition; 2002 Sep 26; 18(9):729-33. PubMed ID: 12297207
    [Abstract] [Full Text] [Related]

  • 18. Six-month efficacy and safety of amfepramone in obese Mexican patients: a double-blinded, randomized, controlled trial.
    Soto-Molina H, Pizarro-Castellanos M, Rosado-Pérez J, Rizzoli-Córdoba A, Lara-Padilla E, del Valle-Laisequilla CF, Reyes-García JG.
    Int J Clin Pharmacol Ther; 2015 Jul 26; 53(7):541-9. PubMed ID: 26073353
    [Abstract] [Full Text] [Related]

  • 19. Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole' Study.
    Lovejoy JC, Bray GA, Lefevre M, Smith SR, Most MM, Denkins YM, Volaufova J, Rood JC, Eldridge AL, Peters JC, Ole' Study.
    Int J Obes Relat Metab Disord; 2003 Oct 26; 27(10):1242-9. PubMed ID: 14513073
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.